Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept

Mayo Clinic Proceedings

Volumn 76, Issue 6, 2001, Pages 653-656

  Bachai, Mercedeh ^a,b,c,d,e   Osmon, Douglas R ^a   Wolk, Donna M ^b   Wold, Lester E ^a   Haidukewych, George J ^c   Matteson, Eric L ^d  

^a Department of Surgery ^*  (United States)

^b Division of Cardiovascular Diseases and Internal Medicine   (United States)

^c Division of Rheumatology and Internal Medicine   (United States)

^d Mavo Clinic   (United States)

^e MAYO CLINIC   (United States)

Author keywords

DMARD = disease modifying antirheumatic drug; NSAID = nonsteroidal anti inflammatory drug; RA = rheumatoid arthritis; WBC = white blood cell

Indexed keywords

ANTIBIOTIC AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CIPROFLOXACIN; CLINDAMYCIN; ETANERCEPT; GLUCOCORTICOID; GOLD; HYDROXYCHLOROQUINE; LEFLUNOMIDE; LEVOFLOXACIN; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN DERIVATIVE; PREDNISONE; SALAZOSULFAPYRIDINE; SERTRALINE; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTHRITIS; ARTICLE; CASE REPORT; DEPRESSION; FEMALE; HIGH RISK PATIENT; HUMAN; KIKUCHI DISEASE; PYELONEPHRITIS; RHEUMATOID ARTHRITIS; SEPSIS; TOTAL KNEE REPLACEMENT;

EID: 0034995201     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.6.653     Document Type: Article

References (14)

1. Ferez CM, Kubak BM, Cryer HG, Salehmugodam S, Vespa P, Farmer D. Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review. AmJMed. 1997;102:111-113.
2. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med. 1996;334:240-245.
3. O'Dell JR. Anticytokine therapy-a new era in the treatment of rheumatoid arthritis? [editorial]. TV Engl J Med. 1999;340:310312.
4. Weinblatt ME, Kremer JM, Bankurst AD, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion
5. protein, in patients with rheumatoid arthritis receiving methotrexate. N Engt J Med. 1999;340:253-259.
6. Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med. 2000;343:1586-1593.
7. Moreland LW, Schiff MH, Baumgartner SW, et al. Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial. Ann Intern Med. 1999; 130:478-486.
8. Lipsky PE, van der Heijde DM, St Clair EW, et al, Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis With Concomitant Therapy Study Group. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med. 2000;343:1594-1602.
9. Choudhri SHR, Brownstone R, Hashem F, Magro CM, Crowson AN. A case of necrotizing fasciitis due to Streptococcus pneumoniae.BrJ Dermatol. 1995;133:128-131.
10. Fernandez Guerrero ML, Martinez Quesada G, Bernacer Borja M, Sarasa Corral JL. Streptococcal gangrene and so-called "flesheating bacteria disease": a rare and devastating disease [in Spanish]. Rev Clin Esp. 1999; 199:84-88.
11. Taylor SN, Sanders CV. Unusual manifestations of invasive pneumococcal infection. Am J Med. 1999;107:12S-27S.
12. Ruoff KL, Whiley RA, Beighton D. Streptococcus. In: Murray PR, Bron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. 7th ed. Washinton, DC: ASM Press; 1999: 283-296.
13. Turesson C, Jacobsson L, Bergström U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford). 1999; 38:668-674.
14. Fisher CJ Jr, Agosti JM, Opal SM, et al, Soluble TNF Receptor Sepsis Study Group. Treatment of septic shock with the tumor necrosis factor receptonFc fusion protein. N Engl J Med. 1996; 334:1697-1702.